Michael Haase
Overview
Explore the profile of Michael Haase including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
6008
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swolinsky J, Hinz R, Markus C, Singer E, Bachmann F, Halleck F, et al.
Nephrol Dial Transplant
. 2023 Oct;
39(3):483-495.
PMID: 37858309
Background: The objective of this study was to investigate the utility of neutrophil gelatinase-associated lipocalin (NGAL) and calprotectin (CPT) to predict long-term graft survival in stable kidney transplant recipients (KTR)....
2.
Iwers R, Sliziuk V, Haase M, Barabasch S, Zanker M, Butter C, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37835034
Detection and timely intervention of acute kidney injury (AKI) is a major challenge worldwide. Electronic alerts for AKI may improve process- and patient-related endpoints. The present study evaluated the efficacy...
3.
Albert A, Haase M, Elitok S, Haase-Fielitz A, Braun-Dullaeus R, Albert C
Ren Fail
. 2023 Sep;
45(2):2241930.
PMID: 37724536
No abstract available.
4.
Nubel J, Hoffmeister M, Labrenz O, Jost K, Oess S, Hauptmann M, et al.
Biomark Med
. 2023 Sep;
17(10):475-485.
PMID: 37675894
This study aimed to determine whether novel and conventional cardiorenal biomarkers in patients before transcatheter aortic valve implantation may be associated with cardiorenal syndrome (CRS) type 1. Serum NT-proBNP and...
5.
Albert A, Radtke S, Blume L, Bellomo R, Haase M, Stieger P, et al.
Ann Lab Med
. 2023 Jun;
43(6):539-553.
PMID: 37387487
Background: We explored the extent to which neutrophil gelatinase-associated lipocalin (NGAL) cutoff value selection and the acute kidney injury (AKI) classification system determine clinical AKI-phenotype allocation and associated outcomes. Methods:...
6.
Kister T, Schmidt M, Heuft L, Federbusch M, Haase M, Kaiser T
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769739
Acute kidney injury (AKI) is a common disease, with high morbidity and mortality rates. In this study, we investigated the potential influence of sex and age on laboratory diagnostics and...
7.
Schumann T, Costas Ramon S, Schubert N, Mayo M, Hega M, Maser K, et al.
J Exp Med
. 2022 Nov;
220(1).
PMID: 36346347
Defects in nucleic acid metabolizing enzymes can lead to spontaneous but selective activation of either cGAS/STING or RIG-like receptor (RLR) signaling, causing type I interferon-driven inflammatory diseases. In these pathophysiological...
8.
Schipmann F, Bannehr M, Hahnel V, Dworok V, Nubel J, Edlinger C, et al.
Diseases
. 2022 Mar;
10(1).
PMID: 35323183
Aim: The impact of chronic kidney disease (CKD) on patient-related outcomes in patients with tricuspid regurgitation (TR) is well known. However, the impact of the progression of CKD in patients...
9.
Haarhaus M, Duhanes M, Lesevic N, Matei B, Ramsauer B, Da Silva Rodrigues R, et al.
Scand J Immunol
. 2022 Mar;
95(5):e13152.
PMID: 35244289
Vaccination against 2019 coronavirus disease (COVID-19) can reduce disease incidence and severity. Dialysis patients demonstrate a delayed immunologic response to vaccines. We determined factors affecting the immunologic response to COVID-19...
10.
Haase M, Lesny P, Anderson M, Cloherty G, Stec M, Haase-Fielitz A, et al.
J Nephrol
. 2022 Jan;
35(5):1467-1478.
PMID: 35084719
Background: After the reports of severe adverse reactions to the AstraZeneca ChAdOx1-S-nCoV-19 vaccine, patients who had received one dose of ChAdOx1-S-nCoV-19 vaccine were recommended a second dose of Pfizer's BNT162b2...